| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 6 |
| 1 | PANITUMUMAB | 6 |
| 2 | BEVACIZUMAB | 5 |
| 3 | CAPECITABINE | 5 |
| 4 | FLUOROURACIL | 5 |
| 5 | FLUOROURACIL CREAM, 0.5% | 5 |
| 6 | BUDESONIDE | 4 |
| 7 | SALMETEROL XINAFOATE | 4 |
| 8 | ALBUTEROL SULFATE | 3 |
| 9 | METHOTREXATE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERAPAMIL HYDROCHLORIDE | 2 | 0.0005 |
| 1 | PANITUMUMAB | 6 | 0.0004 |
| 2 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 2 | 0.0002 |
| 3 | CLOBETASOL PROPIONATE | 2 | 0.0002 |
| 4 | TELMISARTAN | 2 | 0.0001 |
| 5 | APALUTAMIDE | 1 | 0.0001 |
| 6 | OXALIPLATIN | 6 | 0.0001 |
| 7 | PIPERACILLIN AND TAZOBACTAM | 1 | 0.0001 |
| 8 | MUPIROCIN CALCIUM | 1 | 0.0001 |
| 9 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 6 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 3 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |